3RD ANNUAL Next Generation Undruggable
11
Oct
-
11
Oct
2022
When
Boston
Massachusetts
USA
Where

FOCUSED ON INNOVATION Explore cutting edge approaches with the potential to change how we view difficult-to-drug diseases. Bringing the leading experts across multiple disciplines together in one central hub, Next Generation Undruggable will explore shared challenges across all of undruggable with the aim of benefitting the whole industry. CRUCIAL TOPICS Showcasing the next wave of undruggable innovation with exclusive content. Including protein degradation and molecular glues, transcription factors, oligonucleotide approaches and more, plus interactive sessions on AI and Machine Learning as well as the business and partnerships that make these breakthroughs possible. PEER-TO-PEER LEARNING Discuss crucial topics & challenges with leading experts from pharma, biotech & academia through panels with Q&A. Get hands-on with your learning with our roundtable sessions, sharing key insights with your senior-level peers. Discover the case studies that are at the forefront of research and innovation fuelling the next wave of undruggable.

Similar Events

You May Like

(0)
28 November-02 December 2022
Biotechgate Digital Partnering November 2022
(0)
01-02 December 2022
Pre-Filled Syringes & Auto-Injectors Forum 2022
(0)
01-02 December 2022
Pharma Ed’s Cleaning Validation Summit
(0)
01-02 December 2022
Annual Extractables & Leachables Hybrid Conference
(0)
01-02 December 2022
Vaccines Research and Development
(0)
02-03 December 2022
11th Munich Vascular Conference (MAC)
(0)
04-06 December 2022
Assisted & Senior Living Facilities Summit 2022
(0)
04-08 December 2022
Antibody Engineering & Therapeutics
(0)
05-06 December 2022
NGPX 2022
(0)
05-07 December 2022
4th Cell Therapy Analytical Development Summit

Event

GreyGreen

0/5
(0)

Grey Green Media is a boutique event and content house based in central London, England. We produce high-quality executive events including the industry leading Digital Therapeutics Summits (The DTx series). Our focus revolves around the interface between patient need and technology. Our team have over 40 years experience working within event production, content creation and business development - almost exclusively within life sciences and learning and development. We know that high-quality content drives an audience, and an audience coming together drives business. Which is why we spend over 4x the industry average on researching our topics, speaking to the KOL's, the disruptors, the leaders and the next wave of pioneers. We do this with just one single purpose in mind - to uncover the critical questions that really need answering, not just the headline fluff! Learning is at the heart of everything we do. Attending our events is not one-way traffic. Our speakers and our delegates are peers, and both have something to learn from one other. Our sponsors work with us because we know they are always critical to the conversation, helping their customers, and prospective customers, on a daily basis. We are proud of the fact that investment decisions are made as a result of meetings held at our events.

11 - 11 Oct 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Senior Vice President Discovery Chemistry
Chief Scientific Officer
President & CEO
Head of External Innovation, Therapeutics Discovery
CEO & Co-Founder of Totus Medicines
Vice President of DMPK and Preclinical Developmen
Vice President, Global Head Search & Evaluation
Chief Scientific Officer, Early Research
Senior Vice President, Corporate and Business Development
Vice President, Head Oncology Discovery
Vice President

Sponsors and Exhibitors
Brand, Media and Promotional Partners

resistanceBio

Helping patients fight treatment resistant cancer. Resistance Bio can discover and overcome clinical treatment resistance pre-clinically.

PhoreMost Ltd

PhoreMost is a new-model drug discovery company based in Cambridge, UK. We are dedicated to ‘Drugging the Undruggable®’ disease targets using our next-generation technology, SITESEEKER®. Using PROTEINi® libraries, this unique drug target identificati

Organizer

Get emails from us

 
Thank you
Oops! Something went wrong